Dergiler / The Anatolian Journal of Cardiology / 2018 / Cilt: 19 - Sayı: 3

Serial assessment of endothelial vasomotor function using optimal medical therapy predicts clinical outcomes in patients after complete coronary revascularization

Sayfa
177–183
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

A multipleCox hazards analysis showed that OMT was a protective predictor of MACCE (hazard ratio, 0.19; 95% confidence interval, 0.04–0.88, p=0.03).Conclusion: This study demonstrated a significant association between the serial measurement of endothelial function with OMT and the clinicaloutcome in patients after PCI.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Previous studies have demonstrated the importance of intensive optimal medical therapy (OMT) in patients with coronary arterydisease (CAD).
📊
Temel Bulgular & Veri:To investigate our hypothesis that patients with and without OMT achievement differed with respect to the risk of future cardiacevents, we investigated the endothelial function in patients with CAD who underwent percutaneous coronary intervention (PCI) and contemporarymedical therapy.Methods: We conducted a prospective longitudinal cohort study to evaluate the endothelial function in 96 consecutive patients at 12 h afteradmission and 3 months at <12 h after admission and at 3 months after discharge by measuring the brachial artery dilatation after 5 min of forearmischemia flow-mediated dilation (FMD).
💡
Sonuç & Katkı:A multipleCox hazards analysis showed that OMT was a protective predictor of MACCE (hazard ratio, 0.19; 95% confidence interval, 0.04–0.88, p=0.03).Conclusion: This study demonstrated a significant association between the serial measurement of endothelial function with OMT and the clinicaloutcome in patients after PCI.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: Previous studies have demonstrated the importance of intensive optimal medical therapy (OMT) in patients with coronary arterydisease (CAD). To investigate our hypothesis that patients with and without OMT achievement differed with respect to the risk of future cardiacevents, we investigated the endothelial function in patients with CAD who underwent percutaneous coronary intervention (PCI) and contemporarymedical therapy.Methods: We conducted a prospective longitudinal cohort study to evaluate the endothelial function in 96 consecutive patients at 12 h afteradmission and 3 months at <12 h after admission and at 3 months after discharge by measuring the brachial artery dilatation after 5 min of forearmischemia flow-mediated dilation (FMD). OMT achievement was defined as systolic blood pressure of ≤130 mm Hg, low-density lipoproteincholesterol of ≤100 mg/dl, and hemoglobin A1c level of ≤7.0%. The primary endpoint was the incidence of composite major adverse cardiac orcerebrovascular events (MACCE) at 36 months.Results: Forty-nine (51%) patients achieved all three risk factor targets at 3 months. Although baseline FMD values did not differ between theOMT achievement and non-achievement groups, the 3-month FMD significantly improved in the OMT achievement group (6.6±3.5 vs. 5.2±2.9,p=0.03). Patients with improved FMD at 3 months had a lower rate of 36-month MACCE than those with persistently impaired FMD. A multipleCox hazards analysis showed that OMT was a protective predictor of MACCE (hazard ratio, 0.19; 95% confidence interval, 0.04–0.88, p=0.03).Conclusion: This study demonstrated a significant association between the serial measurement of endothelial function with OMT and the clinicaloutcome in patients after PCI.

🔖

Bu Makaleye Atıf Yap

TOKUE, M., IİJİMA, R., MOROİ, M., NAKAMURA, M. (2018). Serial assessment of endothelial vasomotor function using optimal medical therapy predicts clinical outcomes in patients after complete coronary revascularization. The Anatolian Journal of Cardiology, Cilt: 19 - Sayı: 3, 177–183. https://ajindex.com/articles/365249

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Bangalore S, Breazna A, DeMicco DA, Wun CC, Messerli FH
  2. TNT Steering Committee and Investigators. J Am Coll Cardiol 2015
  3. [CrossRef] Drozda JP Jr, Ferguson TB Jr, Jneid H, Krumholz HM, Nallamothu BK, Olin JW, et al. 2015 ACC/AHA Focused Update of Secondary Prevention Lipid Performance Measures: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol 2016
  4. [CrossRef] Geisler T, Zürn C, Paterok M, Göhring-Frischholz K, Bigalke B, Stellos K, et al. Statins do not adversely affect post interventional residual platelet aggregation and outcomes in patients undergoing coronary stenting treated by dual antiplatelet therapy. Eur Heart J 2008
  5. [CrossRef] Narita K, Murata T, Hamada T, Takahashi T, Omori M, Suganuma N, et al. Interactions among higher trait anxiety, sympathetic activity, and endothelial function in the elderly. J Psychiatr Res 2007
  6. [CrossRef] Vlachopoulos C, Ioakeimidis N, Aznaouridis K, Bratsas A, Baou K, Xaplanteris P, et al. Association of interleukin-18 levels with global arterial function and early structural changes in men without cardiovascular disease. Am J Hypertens 2010
  7. [CrossRef] Patel S, Celermajer DS, Bao S. atherosclerosis-underlying inflammatory mechanisms and clinical implications. Int J Biochem Cell Biol 2008
  8. [CrossRef] Clapp BR, Hirschfield GM, Storry C, Gallimore JR, Stidwill RP, Singer M, et al. Inflammation and endothelial function: direct vascular effects of human C-reactive protein on nitric oxide bioavailability. Circulation 2005
  9. [CrossRef] Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007
  10. [CrossRef] De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, et al
  11. FAME 2 Trial Investigators. Fractional flow reserve-guide PCI versus medical therapy in stable coronary disease. N Engl J Med 2012
  12. [CrossRef] Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al
  13. COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007
  14. [CrossRef] Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al: Task Force Members. ESC guide lines on the management of stable coronary artery disease: the Task Force on the manage